Shire establishes U.S. headquarters
Executive Summary
U.K.-based Shire sets up North American headquarters in Wayne, Penn. and plans to close its facilities in Rockville, Md. and Newport, Ky. The new facility will house about 400 employees by end of 2005. Establishing a U.S. headquarters was one step in a streamlining effort announced by CEO Matthew Emmens shortly after he joined the company this spring (1"The Pink Sheet" March 17, 2004, In Brief)...
You may also be interested in...
Shire hires ex-Merck exec
Former Merck KGaA global ethical pharmaceuticals president Matthew Emmens named CEO of Shire effective March 19. Emmens succeeds Rolf Stahel, who announced his intention to leave the company in October. Emmens previously spent 19 years at U.S. Merck & Co., and was CEO of Astra Merck joint venture...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.